Barbieri Thesis - BioMedical Materials program (BMM)
Barbieri Thesis - BioMedical Materials program (BMM)
Barbieri Thesis - BioMedical Materials program (BMM)
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Chapter 3 – Instructive composites: effect of filler content on osteoinduction<br />
the viscosity of the polymer as supplied and the polymer phase in the prepared<br />
materials. In the case of composites, we dissolved the samples in chloroform (CHCl3,<br />
Sigma–Aldrich, Steinhem, Germany) at the concentration of 4 mg mL –1 . We then<br />
separated apatite particles from the polymer component through vacuum filtering with<br />
glass funnels (ROBU, Germany; borosilicate 3.3 with glass filter having porosity #5)<br />
and PTFE membrane filter (Toyo Roshi Kaisha, Advantec, Japan; pore size 0.1 m)<br />
and let chloroform completely evaporate to obtain the polymer samples. Afterwards,<br />
we dissolved again the filtered polymers in chloroform (Sigma–Aldrich) at a<br />
concentration of 0.1 g dL –1 and measured the relative viscosity (rel) using an<br />
Ubbelohde (ASTM) viscometer (0C, PSL–Rheotek, Burnham on Crouch, United<br />
Kingdom) at 25±0.1°C. From rel we could determine the inherent (inh) and<br />
intrinsic () viscosity (Solomon–Ciută equation). [356] Then, by using Mark–<br />
Houwink equation, the weight average molecular weight (Mw) of the polymers was<br />
calculated, as follows: [337]<br />
rel = tpol / tchlor<br />
sp = rel – 1<br />
inh = ln(rel) / ĉ<br />
= [sqrt(2 · (sp – ln(rel) ))] / ĉ<br />
ln(inh) = ln(K) + ā · ln(Mw) from which Mw = exp[ (ln(inh) – ln(K)) / ā ]<br />
where tpol and tchlor are the measured time for the solution of polymer and of pure<br />
chloroform to flow in the viscometer respectively, and ĉ is the polymer concentration<br />
in chloroform. The used Mark–Houwink constants related to inherent viscosity for<br />
poly(D,L–lactide) were K=1.8 · 10 –4 dL g –1 and ā=0.72. [337]<br />
3.2.4. In vitro calcium ion release<br />
A simulated physiological solution (SPS) was prepared by dissolving NaCl (Merck;<br />
c=8 g L –1 ) and 4–(2–hydroxyethyl)–1–piperazineethane–sulfonic acid (HEPES)<br />
(Sigma–Aldrich; c=11.92 g L –1 ) in distilled water. The pH of the solution was adjusted<br />
to 7.3 with 2M NaOH (Sigma–Aldrich). Calcium ion release was evaluated by soaking<br />
the irregularly shaped composite granules (v=0.13 cc) in 100 mL of SPS at 37±1°C<br />
for eight hours. While carefully stirring at 150±5 rpm without touching the samples,<br />
the calcium ion concentration in SPS was recorded every minute using a calcium<br />
electrode (Metrohm 692 ISE meter, Ag/AgCl reference electrode, Metrohm, Herisau,<br />
Switzerland).<br />
3.2.5. In vitro surface mineralization<br />
Simulated body fluid (SBF) was prepared according to Kokubo [247] by dissolving<br />
reagent grade chemicals (Merck) in distilled water strictly in the following order: NaCl,<br />
53